| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pediatrics, Bay state Medical Center Springfield, Massachusetts 01199
The Department of Pediatrics, Children's Hospital of Buffalo Buffalo, New York 14222
Endocrine Sciences, Inc. Tarzana, California 91356
Address requests for reprints to: Dr. Edward O. Jleiter, Department of Pediatrics, Baystate Medical Center, Springfield, Massachusetts 01199.
Many different assays are being used to measure serum GH concentrations in children with disorders of growth. We assessed four readily available methods to determine the comparability of the immunopotency estimates: standard double antibody RIA with pituitary standards from, the National Hor-mone and Pituitary Program (assay 1) and from a commercial source (assay 2), a double antibody RIA with serum standards (assay 4), and a commercial immunoradiometric assay (assay 3). There was a high degree of relative correlation between assays (r = 0.95–0.98), but absolute potency estimates differed. Assays 1 and 2 were almost identical. Assay 3 yielded serum GH levels about 65% those of assay 1 or 2 and 80% those of assay 4. Assay 4 gave intermediate values between the low readings in assay 3 and higher values in assay 1 and 2. We conclude that substantial variation occurs in potency estimates in different GH assays. Such differences can affect the interpretation of many GH provocative and sampling studies.
Received July 10, 1987.
This article has been cited by other articles:
 |
|
 |
|
  M. Bidlingmaier Problems with GH assays and strategies toward standardization Eur. J. Endocrinol., December 1, 2008; 159(suppl_1): S41 - S44. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Markkanen, T. Pekkarinen, M. J. Valimaki, H. Alfthan, R. Kauppinen-Makelin, T. Sane, and U.-H. Stenman Effect of Sex and Assay Method on Serum Concentrations of Growth Hormone in Patients with Acromegaly and in Healthy Controls Clin. Chem., March 1, 2006; 52(3): 468 - 473. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Clemmons and C. Strasburger Monitoring the Response to Treatment in Acromegaly J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5289 - 5291. [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. Nindl, W. C. Hymer, D. R. Deaver, and W. J. Kraemer Growth hormone pulsatility profile characteristics following acute heavy resistance exercise J Appl Physiol, July 1, 2001; 91(1): 163 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Strasburger Methods in Determining Growth Hormone Concentrations: An Immunofunctional Assay Pediatrics, October 1, 1999; 104(4): 1024 - 1028. [Abstract] [Full Text]
|
|
|
|
|
|
P. U. Freda, K. D. Post, J. S. Powell, and S. L. Wardlaw Evaluation of Disease Status with Sensitive Measures of Growth Hormone Secretion in 60 Postoperative Patients with Acromegaly J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3808 - 3816. [Abstract] [Full Text]
|
|
|
|
|
|
Committee on Drugs and Committee on Bioethics Considerations Related to the Use of Recombinant Human Growth Hormone in Children Pediatrics, January 1, 1997; 99(1): 122 - 129. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. L. Seip, A. Weltman, D. Goodman, and A. D. Rogol Clinical Utility of Cycle Exercise for the Physiologic Assessment of Growth Hormone Release in Children Arch Pediatr Adolesc Med, September 1, 1990; 144(9): 998 - 1000. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Lantos, M. Siegler, and L. Cuttler Ethical Issues in Growth Hormone Therapy JAMA, February 17, 1989; 261(7): 1020 - 1024. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
